Skip to main content
. 2017 Jul 11;8(51):89307–89314. doi: 10.18632/oncotarget.19153

Figure 2. Signaling pathways and the role of silibinin in β-thalassemia; acute myeloid leukemia; Anaplastic large cell lymphoma and multiple myelomas.

Figure 2